Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

March 21, 2021

Study Completion Date

March 25, 2021

Conditions
Healthy Subjects
Interventions
DRUG

Trans-Sodium Crocetinate

TSC given as a one-time IV bolus injection

DRUG

Placebo

Placebo normal saline given as a one-time 7 mL one-time IV bolus injection

Trial Locations (1)

66212

Altasciences Clinical Kansas Inc, Overland Park

Sponsors
All Listed Sponsors
lead

Diffusion Pharmaceuticals Inc

INDUSTRY